ALTERATIONS OF MONOAMINE CONTENT BY DECABORANE AFTER MONOAMINE OXIDASE INHIBITION BY IPRONIAZID.
Abstract
Pretreatment of rats with 100 mg. iproniazid/kg. does not prevent the fall of brain and heart norepinephrine content produced by the subsequent injection of 15 mg. decaborane (B10H14)/kg. This phenomenon is in contrast to the effect of the drug combination on rat brain 5-hydroxytryptamine. In this case, pretreatment with iproniazid does prevent the decaborane-mediated decline of brain 5-hydroxytryptamine. The results are discussed in relation to the mechanism of action of decaborane. (Author)
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 1967
- Accession Number
- AD0662325
Entities
People
- James H. Merritt
- Thomas S. Sulkowski
Organizations
- United States Air Force School of Aerospace Medicine